169
Views
4
CrossRef citations to date
0
Altmetric
Articles

Application of molecular docking and PSO–SVR intelligent approaches in antimalarial activity prediction of enantiomeric cycloguanil analogues

, &
Pages 957-974 | Received 13 Jul 2018, Accepted 12 Oct 2018, Published online: 01 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Vivek K. Vyas, Sapna Bhati, Shivani Patel & Manjunath Ghate. (2022) Structure- and ligand-based drug design methods for the modeling of antimalarial agents: a review of updates from 2012 onwards. Journal of Biomolecular Structure and Dynamics 40:20, pages 10481-10506.
Read now
Probir Kumar Ojha, Vinay Kumar, Joyita Roy & Kunal Roy. (2021) Recent advances in quantitative structure–activity relationship models of antimalarial drugs. Expert Opinion on Drug Discovery 16:6, pages 659-695.
Read now
J. Devillers & H. Devillers. (2019) Toxicity profiling and prioritization of plant-derived antimalarial agents. SAR and QSAR in Environmental Research 30:11, pages 801-824.
Read now
A. Geronikaki, A. Petrou, V. Kartsev, P. Eleftheriou, R. Boga, B. Bartolo, E. Crespan, G. Franco & G. Maga. (2019) Molecular docking, design, synthesis and biological evaluation of novel 2,3-aryl-thiazolidin-4-ones as potent NNRTIs. SAR and QSAR in Environmental Research 30:10, pages 697-714.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.